BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 410420)

  • 1. Thyrotropin-releasing hormone--increased catabolism of catecholamines in brains of thyroidectomized rats.
    Marek K; Haubrich DR
    Biochem Pharmacol; 1977 Oct; 26(19):1817-8. PubMed ID: 410420
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible mechanism for the anti-depressant activity of thyrotropin releasing hormone.
    Horst WD; Spirt N
    Life Sci; 1974 Sep; 15(6):1073-82. PubMed ID: 4157277
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnover.
    Keller HH; Bartholini G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R46. PubMed ID: 4276583
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone: evidence by fluorescence histochemistry.
    Constantinidis J; Geissbühler F; Gaillard JM; Hovaguimian T; Tissot R
    Experientia; 1974 Oct; 30(10):1182-3. PubMed ID: 4215671
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.
    Rastogi RB; Singhal RL; Lapierre YD
    Psychopharmacology (Berl); 1980; 72(1):85-91. PubMed ID: 6110219
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: The effect of amantadine on the turnover of catecholamines in the rat brain.
    Brown F; Redfern PH
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():81P-82P. PubMed ID: 4156763
    [No Abstract]   [Full Text] [Related]  

  • 9. Exercise and rat brain catecholamines.
    Brown BS; Van Huss W
    J Appl Physiol; 1973 May; 34(5):664-9. PubMed ID: 4703743
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of the tripeptide pyroglutamyl-histidyl-proline amide (thyrotropin-releasing hormone) with brain norepinephrine metabolism: evidence for an extrahypophyseal action of TRH on central nervous system function.
    Stolk JM; Nisula BC
    Prog Brain Res; 1975; 42():47-56. PubMed ID: 812145
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbon monoxide- and hypoxia-induced effects on catecholamines in the mature and developing rat brain.
    Newby MB; Roberts RJ; Bhatnagar RK
    J Pharmacol Exp Ther; 1978 Jul; 206(1):61-8. PubMed ID: 660558
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of isolation on catecholamine concentration and turnover in discrete areas of the rat brain.
    Thoa NB; Tizabi Y; Jacobowitz DM
    Brain Res; 1977 Aug; 131(2):259-69. PubMed ID: 890457
    [No Abstract]   [Full Text] [Related]  

  • 13. Regression analysis of catecholamine utilization in discrete hypothalamic and forebrain regions of the male rat: effects of thyroidectomy.
    Andersson K; Eneroth P
    Acta Physiol Scand; 1985 Jan; 123(1):105-19. PubMed ID: 3881891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prolonged clonidine administration on catecholamine metabolism in the rat brain.
    Draper AJ; Grimes D; Redfern PH
    J Pharm Pharmacol; 1977 Mar; 29(3):175-7. PubMed ID: 15084
    [No Abstract]   [Full Text] [Related]  

  • 15. Central catecholamine turnover and self-stimulation behaviour.
    Arbuthnott G; Fuxe K; Ungerstedt U
    Brain Res; 1971 Apr; 27(2):406-13. PubMed ID: 5552182
    [No Abstract]   [Full Text] [Related]  

  • 16. TRH on rat conditioned avoidance behavior: interaction with brain catecholamines.
    Mora S; Nasello AG; Fieschi L
    Pharmacol Biochem Behav; 1980 Jul; 13(1):137-9. PubMed ID: 6773073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine concentration and turnover in discrete regions of the brain of the homozygous Brattleboro rat deficient in vasopressin.
    Versteeg DH; Tanaka M; de Kloet ER
    Endocrinology; 1978 Nov; 103(5):1654-61. PubMed ID: 748009
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and behavioural effects of tyrosine hydroxylase inhibition.
    Hanson LC
    Psychopharmacologia; 1967; 11(1):8-17. PubMed ID: 5596865
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.
    Brodie BB; Costa E; Dlabac A; Neff NH; Smookler HH
    J Pharmacol Exp Ther; 1966 Dec; 154(3):493-8. PubMed ID: 5928249
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.